Financial risk management - Credit risk (Details)	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Biopharmaceutical and Academia Customers \| United States
Credit risk
Concentration risk (in percent)	43.00%	45.00%

The percentage of the entity's revenue. [Refer: Revenue]

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 34
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard
-URIDate 2023-03-23

Name:	ifrs-full_PercentageOfEntitysRevenue
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration